Natera (NTRA) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
1.7B
Gross Profit
1.0B
60.30%
Operating Income
-222.3M
-13.10%
Net Income
-190.4M
-11.22%
Balance Sheet Metrics
Total Assets
1.7B
Total Liabilities
465.3M
Shareholders Equity
1.2B
Debt to Equity
0.39
Cash Flow Metrics
Operating Cash Flow
91.1M
Free Cash Flow
58.7M
Revenue & Profitability Trend
Natera Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.7B | 1.1B | 820.2M | 625.5M | 391.0M |
| Cost of Goods Sold | 673.8M | 589.8M | 456.3M | 318.4M | 203.6M |
| Gross Profit | 1.0B | 492.7M | 364.0M | 307.1M | 187.4M |
| Operating Expenses | 1.2B | 939.0M | 905.0M | 775.2M | 403.7M |
| Operating Income | -222.3M | -446.2M | -541.0M | -468.2M | -216.3M |
| Pre-tax Income | -189.7M | -434.5M | -546.8M | -471.1M | -229.6M |
| Income Tax | 695.0K | 271.0K | 978.0K | 618.0K | 98.0K |
| Net Income | -190.4M | -434.8M | -547.8M | -471.7M | -229.7M |
| EPS (Diluted) | - | -$3.78 | -$5.57 | -$5.21 | -$2.84 |
Income Statement Trend
Natera Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 1.4B | 1.3B | 1.2B | 1.1B | 862.7M |
| Non-Current Assets | 284.9M | 183.2M | 182.7M | 143.3M | 69.5M |
| Total Assets | 1.7B | 1.4B | 1.4B | 1.2B | 932.2M |
| Liabilities | |||||
| Current Liabilities | 344.0M | 307.3M | 310.5M | 219.0M | 199.1M |
| Non-Current Liabilities | 121.3M | 369.1M | 378.2M | 364.2M | 246.9M |
| Total Liabilities | 465.3M | 676.4M | 688.7M | 583.2M | 445.9M |
| Equity | |||||
| Total Shareholders Equity | 1.2B | 765.3M | 705.7M | 653.3M | 486.2M |
Balance Sheet Composition
Natera Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -190.4M | -434.8M | -547.8M | -471.7M | -229.7M |
| Operating Cash Flow | 91.1M | -254.2M | -486.8M | -383.1M | -205.6M |
| Investing Activities | |||||
| Capital Expenditures | -66.4M | -39.2M | -47.7M | -41.0M | -19.6M |
| Investing Cash Flow | 148.1M | 168.5M | 330.3M | -205.2M | -331.5M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -82.0K | 235.4M | 463.2M | 550.8M | 470.2M |
| Free Cash Flow | 58.7M | -286.2M | -479.2M | -376.3M | -202.1M |
Cash Flow Trend
Natera Key Financial Ratios
Valuation Ratios
Forward P/E
-142.03
Price to Book
18.84
Price to Sales
12.82
PEG Ratio
-142.03
Profitability Ratios
Profit Margin
-10.36%
Operating Margin
-15.78%
Return on Equity
-18.66%
Return on Assets
-8.87%
Financial Health
Current Ratio
3.87
Debt to Equity
15.78
Beta
1.74
Per Share Data
EPS (TTM)
-$1.48
Book Value per Share
$9.12
Revenue per Share
$14.28
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ntra | 23.5B | - | 18.84 | -18.66% | -10.36% | 15.78 |
| Thermo Fisher | 152.5B | 23.69 | 3.09 | 13.70% | 15.19% | 69.23 |
| Danaher | 140.5B | 37.98 | 2.76 | 7.22% | 15.81% | 34.56 |
| Idexx Laboratories | 42.1B | 48.33 | 29.21 | 59.33% | 22.76% | 73.16 |
| Agilent Technologies | 33.0B | 28.60 | 5.37 | 18.88% | 17.59% | 60.04 |
| Iqvia Holdings | 27.4B | 21.64 | 4.61 | 21.64% | 8.61% | 242.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.